NCT05121662View on ClinicalTrials.gov

COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

154

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

February 13, 2025

Study Completion Date

February 13, 2025

Conditions

Multiple SclerosisCOVID-19

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Columbia University

OTHER